You don’t see Aurora Cannabis (NYSE:ACB) and GW Pharmaceuticals (NASDAQ:GWPH) lumped together very often. The two companies have very different business models, with Aurora producing cannabis for medical and recreational markets while GW focuses on developing and marketing cannabis-based prescription drugs.
Both Aurora Cannabis and GW Pharmaceuticals are marijuana stocks that have attracted significant attention from investors. They’re also both off to a fantastic start in 2019, with Aurora up over 90% and GW soaring more than 70%. But which of these stocks is the better pick now?
The case for Aurora Cannabis
Aurora Cannabis’ immediate growth opportunity is right at home in Canada. The country’s recreational marijuana market opened for business in October 2018. Aurora has quickly become one of the top leaders in that market, capturing a 20% market share in the last quarter.
Capacity is critical for success in Canada.